CAMBRIDGE, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated today announced that it will webcast its presentations at three upcoming investor conferences:
* MASS Opportunities: A Biotechnology Investment Conference (Boston, MA) on Thursday, November 2, 2006 at 2:50 p.m. EST, presented by Michael Partridge, Director, Corporate Communications of Vertex. * Cowen & Co. 7th Annual Global Health Care Conference (London, UK) on Tuesday, November 7, 2006 at 10:00 a.m. GMT (5:00 a.m. EST), presented by Joshua Boger, Ph.D., President and Chief Executive Officer of Vertex. * ThinkEquity Partners ThinkTank (New York, NY) on Friday, November 10, 2006 at 9:40 a.m. EST, presented by John Alam, M.D., Executive Vice President, Medicines Development and Chief Medical Officer of Vertex.
Each presentation will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcasts will also be available on the Company’s website for two weeks following the presentations. To access the webcasts, go to Vertex’s website and select the desired presentation from the ‘Events & Presentations’ page. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex’s press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals Incorporated
CONTACT: Lora Pike, Manager, Investor Relations for Vertex,+1-617-444-6755
Web site: http://www.vrtx.com/
Company News On-Call: http://www.prnewswire.com/comp/938395.html/
